biotech
Bio-AnalystSupplement research
person

Vitamin E

Selected research topic

Men's health

Findings differ across measurements or study conditions. The results below keep them separate.

Findings from a combination study cannot be attributed to this ingredient alone.

Animal and cell findings do not establish the same effect in people.

Some findings concern patients or people with a deficiency.

Publications for this topic
15
Human comparison publications
3
Publications needing review
2

Findings in the studies

  • IVF outcomes

    • No clear difference from the comparison group was found.
      Patient group · Single ingredient · Eight weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: Vitamin E versus placebo in men; within-person pre/post semen measures
      Additional measurement information
      Secondary outcome
      Measurement time
      Eight weeks
  • Outcome needs clarification

    About this measure

    Original outcome name: SDF

    • Results were mixed for this outcome.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Between-group comparison
      Additional measurement information
      Primary outcome
      Measurement time
      study follow-up duration not specified
  • sperm motility

    Human comparison research
    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Within-treatment observation; comparator for motility not reported
      Additional measurement information
      Secondary outcome
      Measurement time
      Not confirmed.
    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study · 75 minutes
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      This is cell research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Study comparison: First supplement mixture vs control
      Measurement time
      75 minutes
  • concentration of seminal fluid

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · after 3 months
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: pre-test versus post-test after the multi-ingredient vitamin/mineral regimen; no between-group compa
      Additional measurement information
      Primary outcome
      Measurement time
      after 3 months
Other measured outcomes (10)
  • count

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · Eight weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Vitamin E versus placebo in men; within-person pre/post semen measures
      Additional measurement information
      Secondary outcome
      Measurement time
      Eight weeks
  • morphology

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · Eight weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Vitamin E versus placebo in men; within-person pre/post semen measures
      Additional measurement information
      Secondary outcome
      Measurement time
      Eight weeks
  • motility

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · Eight weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Vitamin E versus placebo in men; within-person pre/post semen measures
      Additional measurement information
      Secondary outcome
      Measurement time
      Eight weeks
  • rate of normal semen analysis results

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study
      Measurement and study conditions
      Study type
      Other evidence
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      Measurement time
      Not confirmed.
  • sperm concentration

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 3 months
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: Within-participant pre/post treatment; no between-group comparator
      Additional measurement information
      Secondary outcome
      Measurement time
      3 months
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 3 months
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: Within-person change from baseline after combination formulation
      Additional measurement information
      Secondary outcome
      Measurement time
      3 months
  • sperm morphology

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Ingredient combination
      Measurement time
      Not confirmed.
  • Sperm viability

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • sperm volume

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · Eight weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Vitamin E versus placebo in men; within-person pre/post semen measures
      Additional measurement information
      Secondary outcome
      Measurement time
      Eight weeks
  • post-thawing motility

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Ingredient combination
      How results were compared
      Comparison unclear · Study comparison: Beta-carotene plus alpha-tocopherol extender condition; abstract reports no effect on motility
      Additional measurement information
      Secondary outcome
      Measurement time
      After cryopreservation and thawing
  • serum testosterone

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study · 28 days
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Study comparison: tramadol plus vitamin E did not attenuate the reported testicular impairment relative to tramadol ex
      Additional measurement information
      Primary outcome
      Measurement time
      28 days

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • DNA-fragmented spermatozoa · Distinct papers needing additional review: 1Direction unclear: 1
  • testosterone · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Human studies reported both between-group improvement and a within-group change for sperm motility; while Cell studies reported between-group improvement in sperm motility.

These conditions come from related studies and may not describe a single paper.

single- and combination-ingredient studies · Individual ingredient effects cannot be separated · Cell or in-vitro studies; indirect evidence · Includes human studies · Includes patient groups · between-group comparison · within-group comparison

3 publications linked to this result

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
  • Animal and cell findings are indirect evidence.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 31.7 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 131

Papers linked to this topic 15 · distinct papers 15 · papers with a confirmed human comparison 3 · papers needing additional review 2

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • concentration of seminal fluid: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • count: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • DNA-fragmented spermatozoa: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • IVF outcomes: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • morphology: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • post-thawing motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • rate of normal semen analysis results: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • SDF: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • serum testosterone: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm concentration: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • sperm morphology: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm motility: Sources represented in this measurement group: 3 · Distinct papers with human comparisons for this outcome: 1
  • Sperm viability: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm volume: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • testosterone: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

count

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

IVF outcomes

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

morphology

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

motility

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SDF

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm volume

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

concentration of seminal fluid

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm motility

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm concentration

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm concentration

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm motility

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

rate of normal semen analysis results

A change was reported, but the comparison could not be confirmed.

Other evidence · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm morphology

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sperm viability

A change was reported, but the comparison could not be confirmed.

Other evidence · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

post-thawing motility

A change was reported in animal or cell research.

Animal study · indirect · Ingredient combination · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum testosterone

A change was reported in animal or cell research.

Animal study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm motility

A change was reported in animal or cell research.

Cell study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

DNA-fragmented spermatozoa

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

testosterone

The study needs further checking before its result can be interpreted.

Observational study · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Review 2 combination findings and 0 findings that outperformed an ingredient alone.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Cautions reported with another supplement or medication

These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.

와파린Vitamin E's anticoagulant effects amplify the risk of bleeding when combined with blood thinners like warfarin.
AspirinVitamin E's anticoagulant effects amplify the risk of bleeding when combined with blood thinners like aspirin.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

비타민 CIn a triple-blind RCT of 60 women with endometriosis, a combination of Vitamin C (1000 mg/day) and Vitamin E (800 IU/day) for 8 weeks significantly reduced pelvic pain, dysmenorrhea, and dyspareunia compared to placebo.
인삼The combined supplement significantly improved the desire domain of the FSFI compared to placebo.